James Wilbur, Chief Commercial Officer at 10x Genomics, Inc. (TXG), sold 29,436 shares at $42.09 ($1.2M) on 2023-11-20, disclosed to the SEC on 2023-11-22.
Open-market sale of $1.2M TXG by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.09 | 14,718 | $619K | 50.0% |
| 2 | $42.09 | 14,718 | $619K | 50.0% |
| Total | $42.09 avg | 29,436 | $1.2M | 100% |
| Filing → |
| TXG | SELL | 2023-05-25 | $17K | — | Filing → |